| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Chao-Chin Chang, Chia-Lin Chan. A global study of screening intensity and economic status on epidemic control performance during various epidemic periods of COVID-19 mutant strains. Risk analysis : an official publication of the Society for Risk Analysis. 2023-12-11. PMID:38078468. |
compared with the results during either alpha or delta pandemic period, the omicron pandemic has a much higher estimated elasticity coefficient of 1.317 (alpha: 0.827 and delta: 0.885). |
2023-12-11 |
2023-12-17 |
Not clear |
| Debora Ferreira Barreto Vieira, Derick Mendes Bandeira, Marcos Alexandre Nunes da Silva, Ana Luisa Teixeira de Almeida, Mia Araújo, Ana Beatriz Machado, Luis Fernando Lopez Tort, Valéria Pereira Nacife, Marilda M Siqueira, Fernando Couto Motta, Alex Pauvolid-Corrêa, Ortrud Monika Bart. Comparative analysis of SARS-CoV-2 variants Alpha (B.1.1.7), Gamma (P.1), Zeta (P.2) and Delta (B.1.617.2) in Vero-E6 cells: ultrastructural characterization of cytopathology and replication kinetics. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2023-12-11. PMID:38081327. |
comparative analysis of sars-cov-2 variants alpha (b.1.1.7), gamma (p.1), zeta (p.2) and delta (b.1.617.2) in vero-e6 cells: ultrastructural characterization of cytopathology and replication kinetics. |
2023-12-11 |
2023-12-17 |
Not clear |
| Debora Ferreira Barreto Vieira, Derick Mendes Bandeira, Marcos Alexandre Nunes da Silva, Ana Luisa Teixeira de Almeida, Mia Araújo, Ana Beatriz Machado, Luis Fernando Lopez Tort, Valéria Pereira Nacife, Marilda M Siqueira, Fernando Couto Motta, Alex Pauvolid-Corrêa, Ortrud Monika Bart. Comparative analysis of SARS-CoV-2 variants Alpha (B.1.1.7), Gamma (P.1), Zeta (P.2) and Delta (B.1.617.2) in Vero-E6 cells: ultrastructural characterization of cytopathology and replication kinetics. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2023-12-11. PMID:38081327. |
alpha showed the highest mean particle diameter (79 nm), and gamma and delta were the smallest (75 nm). |
2023-12-11 |
2023-12-17 |
Not clear |
| Debora Ferreira Barreto Vieira, Derick Mendes Bandeira, Marcos Alexandre Nunes da Silva, Ana Luisa Teixeira de Almeida, Mia Araújo, Ana Beatriz Machado, Luis Fernando Lopez Tort, Valéria Pereira Nacife, Marilda M Siqueira, Fernando Couto Motta, Alex Pauvolid-Corrêa, Ortrud Monika Bart. Comparative analysis of SARS-CoV-2 variants Alpha (B.1.1.7), Gamma (P.1), Zeta (P.2) and Delta (B.1.617.2) in Vero-E6 cells: ultrastructural characterization of cytopathology and replication kinetics. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2023-12-11. PMID:38081327. |
alpha and gamma had the highest particle frequency per field at 48 hpi, while the same was observed for zeta and delta at 72 hpi and 24 hpi, respectively. |
2023-12-11 |
2023-12-17 |
Not clear |
| Metin Aksu, Priya Kumar, Thomas Güttler, Waltraud Taxer, Kathrin Gregor, Bianka Mußil, Oleh Rymarenko, Kim M Stegmann, Antje Dickmanns, Sabrina Gerber, Wencke Reineking, Claudia Schulz, Timo Henneck, Ahmed Mohamed, Gerhard Pohlmann, Mehmet Ramazanoglu, Kemal Mese, Uwe Groß, Tamar Ben-Yedidia, Oded Ovadia, Dalit Weinstein Fischer, Merav Kamensky, Amir Reichman, Wolfgang Baumgärtner, Maren von Köckritz-Blickwede, Matthias Dobbelstein, Dirk Görlic. Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters. Antiviral research. 2023-12-08. PMID:38065245. |
the primary representative of this group, re32d03, neutralizes alpha to delta as well as omicron ba.2.75; other members neutralize, in addition, omicron ba.1, ba.2, ba.4/5, and xbb.1. |
2023-12-08 |
2023-12-17 |
Not clear |
| Joseph Fokam, Rene Ghislain Essomba, Richard Njouom, Marie-Claire A Okomo, Sara Eyangoh, Celestin Godwe, Bryan Tegomoh, John O Otshudiema, Julius Nwobegahay, Lucy Ndip, Blaise Akenji, Desire Takou, Mohamed M M Moctar, Cleophas Kahtita Mbah, Valantine Ngum Ndze, Martin Maidadi-Foudi, Charles Kouanfack, Sandrine Tonmeu, Dorine Ngono, John Nkengasong, Nicaise Ndembi, Anne-Cecile Z K Bissek, Christian Mouangue, Chanceline B Ndongo, Emilienne Epée, Nadia Mandeng, Sandrine Kamso Belinga, Ahidjo Ayouba, Nicolas Fernandez, Marcel Tongo, Vittorio Colizzi, Gregory-Edie Halle-Ekane, Carlo-Federico Perno, Alexis Ndjolo, Clement B Ndongmo, Judith Shang, Linda Esso, Oliviera de-Tulio, Moussa Moise Diagne, Yap Boum, Georges A E Mballa, Louis R Njoc. Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon. Scientific reports. vol 13. issue 1. 2023-12-08. PMID:38066020. |
of the 760 whole-genome sequences successfully generated by the national genomic surveillance network, 74% were viral sub-lineages of origin and non-variants of concern, 15% delta, 6% omicron, 3% alpha and 2% beta variants. |
2023-12-08 |
2023-12-17 |
Not clear |
| Joseph Fokam, Rene Ghislain Essomba, Richard Njouom, Marie-Claire A Okomo, Sara Eyangoh, Celestin Godwe, Bryan Tegomoh, John O Otshudiema, Julius Nwobegahay, Lucy Ndip, Blaise Akenji, Desire Takou, Mohamed M M Moctar, Cleophas Kahtita Mbah, Valantine Ngum Ndze, Martin Maidadi-Foudi, Charles Kouanfack, Sandrine Tonmeu, Dorine Ngono, John Nkengasong, Nicaise Ndembi, Anne-Cecile Z K Bissek, Christian Mouangue, Chanceline B Ndongo, Emilienne Epée, Nadia Mandeng, Sandrine Kamso Belinga, Ahidjo Ayouba, Nicolas Fernandez, Marcel Tongo, Vittorio Colizzi, Gregory-Edie Halle-Ekane, Carlo-Federico Perno, Alexis Ndjolo, Clement B Ndongmo, Judith Shang, Linda Esso, Oliviera de-Tulio, Moussa Moise Diagne, Yap Boum, Georges A E Mballa, Louis R Njoc. Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon. Scientific reports. vol 13. issue 1. 2023-12-08. PMID:38066020. |
the pandemic was driven by sars-cov-2 lineages of origin in wave 1 (16 weeks, 2.3% cfr), the alpha and beta variants in wave 2 (21 weeks, 1.6% cfr), delta variants in wave 3 (11 weeks, 2.0% cfr), and omicron variants in wave 4 (8 weeks, 0.73% cfr), with a declining trend over time (p = 0.01208). |
2023-12-08 |
2023-12-17 |
Not clear |
| Samuel Clifford, Pauline Waight, Jada Hackman, Stephane Hué, Charlotte M Gower, Freja Cm Kirsebom, Catriona Skarnes, Louise Letley, Jamie Lopez Bernal, Nick Andrews, Stefan Flasche, Elizabeth Mille. Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England. Wellcome open research. vol 8. 2023-12-07. PMID:38058535. |
we estimated the effectiveness of pfizer-biontech mrna vaccine (bnt162b2) and oxford astrazeneca adenovirus vector vaccine (chadox1) vaccines against acquisition and transmission of the alpha and delta variants in a prospective household study in england. |
2023-12-07 |
2023-12-10 |
Not clear |
| Noriaki Wada, Yi Li, Staci Gagne, Takuya Hino, Vladimir I Valtchinov, Elizabeth Gay, Mizuki Nishino, Mark M Hammer, Bruno Madore, Charles R G Guttmann, Kousei Ishigami, Gary M Hunninghake, Bruce D Levy, Kenneth M Kaye, David C Christiani, Hiroto Hatab. Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants. Medicine. vol 102. issue 48. 2023-12-05. PMID:38050198. |
of the 720 coronavirus disease 2019 patients with computed tomography pulmonary angiogram (58.6 ± 17.2 years; 374 females), pe was diagnosed among 42/358 (12%) during the ancestral strain period, 5/60 (8%) during the alpha variant period, 16/152 (11%) during the delta variant period, and 13/150 (9%) during the omicron variant period. |
2023-12-05 |
2023-12-10 |
Not clear |
| Pierre Bay, Christophe Rodriguez, Stefano Caruso, Vanessa Demontant, Laure Boizeau, Alexandre Soulier, Paul L Woerther, Armand Mekontso-Dessap, Jean-Michel Pawlotsky, Nicolas de Prost, Slim Fourat. Omicron induced distinct immune respiratory transcriptomics signatures compared to pre-existing variants in critically ill COVID-19 patients. Journal of medical virology. vol 95. issue 12. 2023-12-05. PMID:38050838. |
eighty-eight patients were included in the study after matching (ancestral [n = 24], alpha [n = 24], delta [n = 22], and omicron [n = 18] variants). |
2023-12-05 |
2023-12-10 |
Not clear |
| Pierre Bay, Christophe Rodriguez, Stefano Caruso, Vanessa Demontant, Laure Boizeau, Alexandre Soulier, Paul L Woerther, Armand Mekontso-Dessap, Jean-Michel Pawlotsky, Nicolas de Prost, Slim Fourat. Omicron induced distinct immune respiratory transcriptomics signatures compared to pre-existing variants in critically ill COVID-19 patients. Journal of medical virology. vol 95. issue 12. 2023-12-05. PMID:38050838. |
in comparison with the ancestral variant, there was a reduced expression of neutrophil degranulation, t cell activation, cytokines signalling pathways in patients infected with alpha and delta variants. |
2023-12-05 |
2023-12-10 |
Not clear |
| Atsushi Suzuki, Kensuke Fukumitsu, Jun Fukihara, Takuma Katano, Hisashi Kako, Yuri Maeda, Makoto Ishii, Akio Niimi, Kazuyoshi Imaizumi, Etsuro Yamaguch. Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases. Journal of chemotherapy (Florence, Italy). 2023-12-04. PMID:38044564. |
the oxygen deterioration rate after initiation of treatment significantly decreased in the omicron variant phase compared to the alpha and delta variant phases. |
2023-12-04 |
2023-12-10 |
Not clear |
| Saina Beitari, Gerard Agbayani, Melissa Hewitt, Diana Duque, Jegarubee Bavananthasivam, Jagdeep K Sandhu, Bassel Akache, Ita Hadžisejdić, Anh Tra. Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both. Scientific reports. vol 13. issue 1. 2023-12-04. PMID:38049498. |
hamsters vaccinated with two doses of vsv expressing sars-cov-2 spike, both delivered by in or im + in, showed strong protection against sars-cov-2 variants of concern alpha and delta. |
2023-12-04 |
2023-12-10 |
mouse |
| Anurima Samanta, Priyanka Saha, Olivia Johnson, Anupam Bishayee, Dona Sinh. Dysregulation of delta Np63 alpha in squamous cell carcinoma and its therapeutic targeting. Biochimica et biophysica acta. Reviews on cancer. 2023-12-01. PMID:38040268. |
dysregulation of delta np63 alpha in squamous cell carcinoma and its therapeutic targeting. |
2023-12-01 |
2023-12-10 |
Not clear |
| Anurima Samanta, Priyanka Saha, Olivia Johnson, Anupam Bishayee, Dona Sinh. Dysregulation of delta Np63 alpha in squamous cell carcinoma and its therapeutic targeting. Biochimica et biophysica acta. Reviews on cancer. 2023-12-01. PMID:38040268. |
delta np63 (∆np63) is a p63 family member gene with several isoforms, among which delta np63 alpha (∆np63α) is the predominant isoform expressed in the basal layer of stratified epithelia. |
2023-12-01 |
2023-12-10 |
Not clear |
| Xu Li, Ningtao Cheng, Danrong Shi, Yutong Li, Chen Li, Miaojin Zhu, Qiao Jin, Zhigang Wu, Linwei Zhu, Yi He, Hangping Yao, Jian J. Sulfated liposome-based artificial cell membrane glycocalyx nanodecoys for coronavirus inactivation by membrane fusion. Bioactive materials. vol 33. 2023-12-01. PMID:38024234. |
to tackle this challenge, sulfated liposomes are employed to mimic the cell membrane glycocalyx for constructing an artificial cell membrane glycocalyx nanodecoy that exhibits excellent anti-coronavirus activity against hcov-oc43, wild-type sars-cov-2, alpha and delta variant sars-cov-2 pseudovirus. |
2023-12-01 |
2023-12-07 |
Not clear |
| Xu Li, Ningtao Cheng, Danrong Shi, Yutong Li, Chen Li, Miaojin Zhu, Qiao Jin, Zhigang Wu, Linwei Zhu, Yi He, Hangping Yao, Jian J. Sulfated liposome-based artificial cell membrane glycocalyx nanodecoys for coronavirus inactivation by membrane fusion. Bioactive materials. vol 33. 2023-12-01. PMID:38024234. |
to tackle this challenge, sulfated liposomes are employed to mimic the cell membrane glycocalyx for constructing an artificial cell membrane glycocalyx nanodecoy that exhibits excellent anti-coronavirus activity against hcov-oc43, wild-type sars-cov-2, alpha and delta variant sars-cov-2 pseudovirus. |
2023-11-29 |
2023-12-07 |
Not clear |
| Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, Clara Mazagatos, Goranka Petrović, F Annabel Niessen, Ausenda Machado, Odile Launay, Sarah Denayer, Lucie Seyler, Joaquin Baruch, Cristina Burgui, Isabela I Loghin, Lisa Domegan, Roberta Vaikutytė, Petr Husa, George Panagiotakopoulos, Nassera Aouali, Ralf Dürrwald, Jennifer Howard, Francisco Pozo, Bartolomé Sastre-Palou, Diana Nonković, Mirjam J Knol, Irina Kislaya, Liem Binh Luong Nguyen, Nathalie Bossuyt, Thomas Demuyser, Aušra Džiugytė, Iván Martínez-Baz, Corneliu Popescu, Róisín Duffy, Monika Kuliešė, Lenka Součková, Stella Michelaki, Marc Simon, Janine Reiche, María Teresa Otero-Barrós, Zvjezdana Lovrić Makarić, Patricia Cjl Bruijning-Verhagen, Verónica Gomez, Zineb Lesieur, Cyril Barbezange, Els Van Nedervelde, Maria-Louise Borg, Jesús Castilla, Mihaela Lazar, Joan O'Donnell, Indrė Jonikaitė, Regina Demlová, Marina Amerali, Gil Wirtz, Kristin Tolksdorf, Marta Valenciano, Sabrina Bacci, Esther Kisslin. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. vol 28. issue 47. 2023-11-25. PMID:37997666. |
introductiontwo large multicentre european hospital networks have estimated vaccine effectiveness (ve) against covid-19 since 2021.aimwe aimed to measure ve against pcr-confirmed sars-cov-2 in hospitalised severe acute respiratory illness (sari) patients ≥ 20 years, combining data from these networks during alpha (march-june)- and delta (june-december)-dominant periods, 2021.methodsforty-six participating hospitals across 14 countries follow a similar generic protocol using the test-negative case-control design. |
2023-11-25 |
2023-11-28 |
Not clear |
| Michele Equestre, Cinzia Marcantonio, Nadia Marascio, Federica Centofanti, Antonio Martina, Matteo Simeoni, Elisabetta Suffredini, Giuseppina La Rosa, Giusy Bonanno Ferraro, Pamela Mancini, Carolina Veneri, Giovanni Matera, Angela Quirino, Angela Costantino, Stefania Taffon, Elena Tritarelli, Carmelo Campanella, Giulio Pisani, Roberto Nisini, Enea Spada, Paola Verde, Anna Rita Ciccaglione, Roberto Brun. Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy. Microorganisms. vol 11. issue 11. 2023-11-25. PMID:38004723. |
in 2020 and 2021, we identified several variants, including b.1.258 (4/67), b.1.177 (9/67), alpha (b.1.1.7, 9/67), gamma (p.1.1, 4/67), and delta (4/67). |
2023-11-25 |
2023-11-28 |
Not clear |
| Alexander Kuc, Ivan Skorokhodov, Alexey Semirechenko, Guzal Khayrullina, Vladimir Maksimenko, Anton Varlamov, Susanna Gordleeva, Alexander Hramo. Oscillatory Responses to Tactile Stimuli of Different Intensity. Sensors (Basel, Switzerland). vol 23. issue 22. 2023-11-25. PMID:38005672. |
eeg cluster analysis revealed a decrease in alpha and beta range (mu-rhythm) as well as theta and delta increase most pronounced to the most salient and fastest type of stimulation. |
2023-11-25 |
2023-11-28 |
human |